

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.69591739 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.69591739 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.41446555 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.27650361 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.90841036 |
| 6 | macrophage activation involved in immune response (GO:0002281) | 4.81151839 |
| 7 | detection of other organism (GO:0098543) | 4.78151512 |
| 8 | detection of bacterium (GO:0016045) | 4.73723032 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 4.55194420 |
| 10 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.54355857 |
| 11 | response to peptidoglycan (GO:0032494) | 4.46026235 |
| 12 | creatine metabolic process (GO:0006600) | 4.45085219 |
| 13 | detection of external biotic stimulus (GO:0098581) | 4.06880747 |
| 14 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.03879730 |
| 15 | transcription from mitochondrial promoter (GO:0006390) | 3.98198742 |
| 16 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.92774070 |
| 17 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.86791474 |
| 18 | cytidine deamination (GO:0009972) | 3.83988069 |
| 19 | cytidine metabolic process (GO:0046087) | 3.83988069 |
| 20 | cytidine catabolic process (GO:0006216) | 3.83988069 |
| 21 | germinal center formation (GO:0002467) | 3.80494511 |
| 22 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.80473108 |
| 23 | cellular response to type I interferon (GO:0071357) | 3.79321635 |
| 24 | type I interferon signaling pathway (GO:0060337) | 3.79321635 |
| 25 | muscle filament sliding (GO:0030049) | 3.77915766 |
| 26 | actin-myosin filament sliding (GO:0033275) | 3.77915766 |
| 27 | response to type I interferon (GO:0034340) | 3.77790762 |
| 28 | detection of molecule of bacterial origin (GO:0032490) | 3.76836219 |
| 29 | apoptotic process involved in morphogenesis (GO:0060561) | 3.73807271 |
| 30 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.73406486 |
| 31 | response to host immune response (GO:0052572) | 3.73406486 |
| 32 | cellular extravasation (GO:0045123) | 3.70458282 |
| 33 | labyrinthine layer development (GO:0060711) | 3.69824904 |
| 34 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.68297285 |
| 35 | sarcomere organization (GO:0045214) | 3.65095901 |
| 36 | cellular response to zinc ion (GO:0071294) | 3.64911518 |
| 37 | leukocyte aggregation (GO:0070486) | 3.64694338 |
| 38 | defense response to protozoan (GO:0042832) | 3.62551913 |
| 39 | respiratory burst (GO:0045730) | 3.61616344 |
| 40 | regulation of mast cell degranulation (GO:0043304) | 3.59446529 |
| 41 | B cell mediated immunity (GO:0019724) | 3.52975806 |
| 42 | response to muramyl dipeptide (GO:0032495) | 3.51354577 |
| 43 | detection of biotic stimulus (GO:0009595) | 3.49165674 |
| 44 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.48761288 |
| 45 | regulation of antigen processing and presentation (GO:0002577) | 3.43250047 |
| 46 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.41811264 |
| 47 | response to host (GO:0075136) | 3.41811264 |
| 48 | response to host defenses (GO:0052200) | 3.41811264 |
| 49 | trophectodermal cell differentiation (GO:0001829) | 3.41250535 |
| 50 | neutrophil activation (GO:0042119) | 3.38928218 |
| 51 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.38579046 |
| 52 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.38021719 |
| 53 | myeloid cell activation involved in immune response (GO:0002275) | 3.37374576 |
| 54 | response to interleukin-15 (GO:0070672) | 3.36679143 |
| 55 | NIK/NF-kappaB signaling (GO:0038061) | 3.35170947 |
| 56 | microglial cell activation (GO:0001774) | 3.33678174 |
| 57 | macrophage activation (GO:0042116) | 3.31668295 |
| 58 | response to protozoan (GO:0001562) | 3.30419720 |
| 59 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.29887354 |
| 60 | proline biosynthetic process (GO:0006561) | 3.29862981 |
| 61 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.29116227 |
| 62 | positive regulation of mast cell activation (GO:0033005) | 3.28983728 |
| 63 | positive regulation of protein homooligomerization (GO:0032464) | 3.25081930 |
| 64 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.24898659 |
| 65 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.24413112 |
| 66 | T-helper 1 type immune response (GO:0042088) | 3.22370559 |
| 67 | granulocyte activation (GO:0036230) | 3.21543349 |
| 68 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.17148483 |
| 69 | B cell homeostasis (GO:0001782) | 3.17105282 |
| 70 | negative regulation of T cell mediated immunity (GO:0002710) | 3.16973393 |
| 71 | cellular response to interleukin-15 (GO:0071350) | 3.15656554 |
| 72 | positive regulation of interferon-alpha production (GO:0032727) | 3.14632587 |
| 73 | positive regulation of antigen processing and presentation (GO:0002579) | 3.14218007 |
| 74 | regulation of skeletal muscle contraction (GO:0014819) | 3.13505486 |
| 75 | B cell receptor signaling pathway (GO:0050853) | 3.13322968 |
| 76 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.11834229 |
| 77 | regulation of leukocyte degranulation (GO:0043300) | 3.11775011 |
| 78 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.11635755 |
| 79 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.10835036 |
| 80 | regulation of integrin activation (GO:0033623) | 3.09912591 |
| 81 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.09315205 |
| 82 | regulation of mast cell activation (GO:0033003) | 3.07932815 |
| 83 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.07502545 |
| 84 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.01293304 |
| 85 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.00768218 |
| 86 | regulation of interferon-alpha production (GO:0032647) | 2.99923116 |
| 87 | myeloid dendritic cell differentiation (GO:0043011) | 2.99637316 |
| 88 | negative regulation of phagocytosis (GO:0050765) | 2.98154815 |
| 89 | T cell migration (GO:0072678) | 2.95471166 |
| 90 | intestinal epithelial cell development (GO:0060576) | 2.94819451 |
| 91 | negative thymic T cell selection (GO:0045060) | 2.94218023 |
| 92 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.93260748 |
| 93 | negative regulation of innate immune response (GO:0045824) | 2.91361347 |
| 94 | determination of adult lifespan (GO:0008340) | 2.90204189 |
| 95 | myeloid dendritic cell activation (GO:0001773) | 2.90203641 |
| 96 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.88268084 |
| 97 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.87666741 |
| 98 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.87250022 |
| 99 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.86848100 |
| 100 | mitotic G1/S transition checkpoint (GO:0044819) | 2.86766131 |
| 101 | positive regulation of type 2 immune response (GO:0002830) | 2.86756760 |
| 102 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.86264948 |
| 103 | protein localization to endosome (GO:0036010) | 2.85938289 |
| 104 | immunoglobulin mediated immune response (GO:0016064) | 2.84970027 |
| 105 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.84885173 |
| 106 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.84079429 |
| 107 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.83589008 |
| 108 | positive regulation of histone deacetylation (GO:0031065) | 2.83173580 |
| 109 | maternal placenta development (GO:0001893) | 2.83057424 |
| 110 | regulation of gamma-delta T cell activation (GO:0046643) | 2.82913888 |
| 111 | tolerance induction (GO:0002507) | 2.82683390 |
| 112 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.82349009 |
| 113 | mitochondrial DNA metabolic process (GO:0032042) | 2.82313039 |
| 114 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.82279004 |
| 115 | cellular response to interferon-gamma (GO:0071346) | 2.81794603 |
| 116 | formation of translation preinitiation complex (GO:0001731) | 2.80232887 |
| 117 | response to laminar fluid shear stress (GO:0034616) | 2.78836808 |
| 118 | positive regulation of lamellipodium assembly (GO:0010592) | 2.78653138 |
| 119 | actin-mediated cell contraction (GO:0070252) | 2.76405585 |
| 120 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.76364439 |
| 121 | regulation of B cell differentiation (GO:0045577) | 2.75187424 |
| 122 | positive regulation of B cell differentiation (GO:0045579) | 2.74915162 |
| 123 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.71599892 |
| 124 | carnitine shuttle (GO:0006853) | 2.68925411 |
| 125 | regulation of translational fidelity (GO:0006450) | 2.67685860 |
| 126 | positive regulation of protein oligomerization (GO:0032461) | 2.67634335 |
| 127 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.64595080 |
| 128 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.64595080 |
| 129 | myofibril assembly (GO:0030239) | 2.62466182 |
| 130 | retinoic acid receptor signaling pathway (GO:0048384) | 2.61349763 |
| 131 | positive thymic T cell selection (GO:0045059) | 2.60641275 |
| 132 | negative regulation of interleukin-12 production (GO:0032695) | 2.59899498 |
| 133 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.57537506 |
| 134 | negative regulation of cell size (GO:0045792) | 2.57313148 |
| 135 | cellular response to osmotic stress (GO:0071470) | 2.56773654 |
| 136 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.55954902 |
| 137 | regulation of gene silencing by miRNA (GO:0060964) | 2.55954902 |
| 138 | regulation of gene silencing by RNA (GO:0060966) | 2.55954902 |
| 139 | negative regulation of nucleotide catabolic process (GO:0030812) | 2.55470008 |
| 140 | embryonic process involved in female pregnancy (GO:0060136) | 2.53188169 |
| 141 | skeletal muscle contraction (GO:0003009) | 2.53158095 |
| 142 | regulation of translation in response to stress (GO:0043555) | 2.51588958 |
| 143 | positive regulation of protein deacetylation (GO:0090312) | 2.51410594 |
| 144 | cellular hyperosmotic response (GO:0071474) | 2.51313095 |
| 145 | muscle organ morphogenesis (GO:0048644) | 2.50584333 |
| 146 | heme transport (GO:0015886) | 2.49636874 |
| 147 | cardiac muscle cell development (GO:0055013) | 2.49554479 |
| 148 | negative regulation of stress fiber assembly (GO:0051497) | 2.49431495 |
| 149 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 2.48763912 |
| 150 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.47960830 |
| 151 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.47953119 |
| 152 | mannose metabolic process (GO:0006013) | 2.47490915 |
| 153 | proline metabolic process (GO:0006560) | 2.44877627 |
| 154 | interferon-gamma secretion (GO:0072643) | 2.43127876 |
| 155 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.43086585 |
| 156 | regulation of superoxide anion generation (GO:0032928) | 2.42999832 |
| 157 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.42762253 |
| 158 | fatty acid transmembrane transport (GO:1902001) | 2.42248065 |
| 159 | apoptotic process involved in development (GO:1902742) | 2.41618413 |
| 160 | negative regulation of purine nucleotide catabolic process (GO:0033122) | 2.39131292 |
| 161 | biotin metabolic process (GO:0006768) | 2.39093937 |
| 162 | actin filament-based movement (GO:0030048) | 2.38776071 |
| 163 | low-density lipoprotein particle clearance (GO:0034383) | 2.36475758 |
| 164 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.36109810 |
| 165 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.34989360 |
| 166 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.34989360 |
| 167 | modulation by symbiont of host immune response (GO:0052553) | 2.34989360 |
| 168 | positive regulation by symbiont of host defense response (GO:0052509) | 2.34989360 |
| 169 | modulation by symbiont of host defense response (GO:0052031) | 2.34989360 |
| 170 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.34989360 |
| 171 | plasma membrane repair (GO:0001778) | 2.34224799 |
| 172 | negative regulation of interleukin-8 production (GO:0032717) | 2.30716326 |
| 173 | pentose-phosphate shunt (GO:0006098) | 2.30262680 |
| 174 | mitochondrial fusion (GO:0008053) | 2.30259728 |
| 175 | positive regulation of lamellipodium organization (GO:1902745) | 2.29768422 |
| 176 | hypotonic response (GO:0006971) | 2.28742838 |
| 177 | negative regulation of interleukin-6 production (GO:0032715) | 2.28679969 |
| 178 | membrane raft organization (GO:0031579) | 2.27977534 |
| 179 | cardiac cell development (GO:0055006) | 2.27072500 |
| 180 | G1 DNA damage checkpoint (GO:0044783) | 2.26343032 |
| 181 | * embryonic placenta development (GO:0001892) | 2.25751968 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.26264144 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.69246352 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.68940657 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 2.65405053 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.51575180 |
| 6 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.51126045 |
| 7 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.43195174 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.23970803 |
| 9 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.11739219 |
| 10 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.10355167 |
| 11 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.07367007 |
| 12 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.04956266 |
| 13 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.04956266 |
| 14 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.04956266 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.03462508 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.02736263 |
| 17 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.01114065 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.95481303 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.94087026 |
| 20 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.92155018 |
| 21 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.90671896 |
| 22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.90244863 |
| 23 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.83518949 |
| 24 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.82779936 |
| 25 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82692524 |
| 26 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.81358921 |
| 27 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.72593525 |
| 28 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.68264765 |
| 29 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.67681487 |
| 30 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.65090825 |
| 31 | MAF_26560356_Chip-Seq_TH1_Human | 1.63505054 |
| 32 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.63424128 |
| 33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.63252280 |
| 34 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.62447939 |
| 35 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.60968688 |
| 36 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.60926742 |
| 37 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.60911130 |
| 38 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.60516748 |
| 39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.59508291 |
| 40 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.55994670 |
| 41 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.55303008 |
| 42 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.53802677 |
| 43 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.53368428 |
| 44 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.52992244 |
| 45 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.51668298 |
| 46 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49896101 |
| 47 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.49773887 |
| 48 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.48687842 |
| 49 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44894097 |
| 50 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.44536880 |
| 51 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.43360939 |
| 52 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.43172048 |
| 53 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.42992408 |
| 54 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.42086810 |
| 55 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.40447516 |
| 56 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38246252 |
| 57 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.37830162 |
| 58 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.37818074 |
| 59 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.36232423 |
| 60 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.35189195 |
| 61 | UTX_26944678_Chip-Seq_JUKART_Human | 1.35109704 |
| 62 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.33851042 |
| 63 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.33419943 |
| 64 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.32865950 |
| 65 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.30921342 |
| 66 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.30381247 |
| 67 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28895246 |
| 68 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27554544 |
| 69 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.26986968 |
| 70 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.26943175 |
| 71 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26397937 |
| 72 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25791828 |
| 73 | MAF_26560356_Chip-Seq_TH2_Human | 1.24779947 |
| 74 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.24063915 |
| 75 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23631070 |
| 76 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.22758962 |
| 77 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.22314786 |
| 78 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.22069883 |
| 79 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21946463 |
| 80 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20698253 |
| 81 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19965366 |
| 82 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19086961 |
| 83 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.18551068 |
| 84 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.18168134 |
| 85 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.17772861 |
| 86 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.16050444 |
| 87 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.15947555 |
| 88 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.15493609 |
| 89 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14767369 |
| 90 | SPI1_23127762_ChIP-Seq_K562_Human | 1.14585774 |
| 91 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.13426659 |
| 92 | ATF3_27146783_Chip-Seq_COLON_Human | 1.13399064 |
| 93 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13183032 |
| 94 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.12632654 |
| 95 | MYB_26560356_Chip-Seq_TH1_Human | 1.11487081 |
| 96 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.11467157 |
| 97 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.11419972 |
| 98 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.11344098 |
| 99 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.10609514 |
| 100 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.09965807 |
| 101 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.09738345 |
| 102 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.09577901 |
| 103 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09451874 |
| 104 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.09339577 |
| 105 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.08369001 |
| 106 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.07531248 |
| 107 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06594838 |
| 108 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06548361 |
| 109 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05413338 |
| 110 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.05398769 |
| 111 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05260914 |
| 112 | P68_20966046_ChIP-Seq_HELA_Human | 1.04955670 |
| 113 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.04863840 |
| 114 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04646686 |
| 115 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.04443915 |
| 116 | GATA1_19941826_ChIP-Seq_K562_Human | 1.04443826 |
| 117 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.03799007 |
| 118 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.03755382 |
| 119 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.03679225 |
| 120 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03177053 |
| 121 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.02703978 |
| 122 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.02649830 |
| 123 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02450700 |
| 124 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.02264247 |
| 125 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.02253171 |
| 126 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.01502041 |
| 127 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.01032287 |
| 128 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.00944280 |
| 129 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.00098210 |
| 130 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.99886993 |
| 131 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.99590836 |
| 132 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.99467276 |
| 133 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.99402306 |
| 134 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99112894 |
| 135 | GATA1_22025678_ChIP-Seq_K562_Human | 0.98457221 |
| 136 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.97529864 |
| 137 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.96931591 |
| 138 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.94670335 |
| 139 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94496582 |
| 140 | MYB_26560356_Chip-Seq_TH2_Human | 0.93703874 |
| 141 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93413526 |
| 142 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.93266113 |
| 143 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.93074538 |
| 144 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.92206281 |
| 145 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.91798209 |
| 146 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.91794957 |
| 147 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.91573261 |
| 148 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.88739206 |
| 149 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.88391413 |
| 150 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87533653 |
| 151 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.87061418 |
| 152 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.86183434 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 3.61605753 |
| 2 | MP0009840_abnormal_foam_cell | 3.12906454 |
| 3 | MP0003646_muscle_fatigue | 2.93710186 |
| 4 | MP0009785_altered_susceptibility_to | 2.67392088 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 2.42737015 |
| 6 | MP0009278_abnormal_bone_marrow | 2.24462319 |
| 7 | MP0000749_muscle_degeneration | 2.23388484 |
| 8 | MP0003763_abnormal_thymus_physiology | 2.17344970 |
| 9 | MP0004084_abnormal_cardiac_muscle | 2.07281083 |
| 10 | MP0000747_muscle_weakness | 2.04832977 |
| 11 | MP0000750_abnormal_muscle_regeneration | 2.02829064 |
| 12 | MP0002269_muscular_atrophy | 2.00003992 |
| 13 | MP0003303_peritoneal_inflammation | 1.99814815 |
| 14 | MP0005058_abnormal_lysosome_morphology | 1.99639686 |
| 15 | MP0005330_cardiomyopathy | 1.99267509 |
| 16 | MP0008057_abnormal_DNA_replication | 1.97634207 |
| 17 | MP0000751_myopathy | 1.94964735 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 1.91155210 |
| 19 | MP0004087_abnormal_muscle_fiber | 1.90154995 |
| 20 | MP0002837_dystrophic_cardiac_calcinosis | 1.86185966 |
| 21 | MP0001800_abnormal_humoral_immune | 1.84811631 |
| 22 | MP0001533_abnormal_skeleton_physiology | 1.84601026 |
| 23 | MP0000685_abnormal_immune_system | 1.83878934 |
| 24 | MP0010155_abnormal_intestine_physiology | 1.81654020 |
| 25 | MP0004036_abnormal_muscle_relaxation | 1.81552143 |
| 26 | MP0005464_abnormal_platelet_physiology | 1.80202425 |
| 27 | MP0004185_abnormal_adipocyte_glucose | 1.77217814 |
| 28 | MP0003828_pulmonary_edema | 1.75589702 |
| 29 | MP0001835_abnormal_antigen_presentation | 1.73426189 |
| 30 | MP0005310_abnormal_salivary_gland | 1.71253219 |
| 31 | MP0004510_myositis | 1.71222892 |
| 32 | MP0003183_abnormal_peptide_metabolism | 1.70680158 |
| 33 | MP0002106_abnormal_muscle_physiology | 1.69512260 |
| 34 | MP0005387_immune_system_phenotype | 1.68578983 |
| 35 | MP0001790_abnormal_immune_system | 1.68578983 |
| 36 | MP0006082_CNS_inflammation | 1.62953869 |
| 37 | MP0010352_gastrointestinal_tract_polyps | 1.61716170 |
| 38 | MP0003806_abnormal_nucleotide_metabolis | 1.60331167 |
| 39 | MP0003566_abnormal_cell_adhesion | 1.60330092 |
| 40 | MP0002332_abnormal_exercise_endurance | 1.56105376 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.51987370 |
| 42 | MP0010630_abnormal_cardiac_muscle | 1.50574316 |
| 43 | MP0002138_abnormal_hepatobiliary_system | 1.50482832 |
| 44 | MP0005451_abnormal_body_composition | 1.48893079 |
| 45 | MP0002452_abnormal_antigen_presenting | 1.46806484 |
| 46 | MP0008469_abnormal_protein_level | 1.43311435 |
| 47 | MP0000759_abnormal_skeletal_muscle | 1.42665693 |
| 48 | MP0003221_abnormal_cardiomyocyte_apopto | 1.42054592 |
| 49 | MP0004145_abnormal_muscle_electrophysio | 1.39956700 |
| 50 | MP0005666_abnormal_adipose_tissue | 1.39767239 |
| 51 | MP0004130_abnormal_muscle_cell | 1.38715978 |
| 52 | MP0003075_altered_response_to | 1.38457280 |
| 53 | MP0000689_abnormal_spleen_morphology | 1.36747796 |
| 54 | MP0004957_abnormal_blastocyst_morpholog | 1.31778914 |
| 55 | MP0009764_decreased_sensitivity_to | 1.30010324 |
| 56 | MP0002998_abnormal_bone_remodeling | 1.28626450 |
| 57 | MP0003950_abnormal_plasma_membrane | 1.27638489 |
| 58 | MP0002723_abnormal_immune_serum | 1.25093419 |
| 59 | MP0000465_gastrointestinal_hemorrhage | 1.25068401 |
| 60 | MP0002396_abnormal_hematopoietic_system | 1.23024156 |
| 61 | MP0002132_abnormal_respiratory_system | 1.21838560 |
| 62 | MP0002405_respiratory_system_inflammati | 1.21810171 |
| 63 | MP0005369_muscle_phenotype | 1.21485766 |
| 64 | MP0000703_abnormal_thymus_morphology | 1.20873681 |
| 65 | MP0003436_decreased_susceptibility_to | 1.19811702 |
| 66 | MP0000733_abnormal_muscle_development | 1.19701586 |
| 67 | MP0002420_abnormal_adaptive_immunity | 1.18821937 |
| 68 | MP0003453_abnormal_keratinocyte_physiol | 1.18409218 |
| 69 | MP0003866_abnormal_defecation | 1.18028490 |
| 70 | MP0001873_stomach_inflammation | 1.17122094 |
| 71 | MP0000343_altered_response_to | 1.16906938 |
| 72 | MP0005000_abnormal_immune_tolerance | 1.16839688 |
| 73 | MP0001819_abnormal_immune_cell | 1.16641987 |
| 74 | MP0002398_abnormal_bone_marrow | 1.16194012 |
| 75 | MP0002722_abnormal_immune_system | 1.16031899 |
| 76 | MP0003172_abnormal_lysosome_physiology | 1.16023887 |
| 77 | MP0005076_abnormal_cell_differentiation | 1.15201290 |
| 78 | MP0009333_abnormal_splenocyte_physiolog | 1.14655452 |
| 79 | MP0000858_altered_metastatic_potential | 1.14194661 |
| 80 | MP0000716_abnormal_immune_system | 1.13840807 |
| 81 | MP0005670_abnormal_white_adipose | 1.12161158 |
| 82 | MP0004381_abnormal_hair_follicle | 1.11881164 |
| 83 | MP0003111_abnormal_nucleus_morphology | 1.11149050 |
| 84 | MP0006036_abnormal_mitochondrial_physio | 1.10644983 |
| 85 | MP0005166_decreased_susceptibility_to | 1.10617520 |
| 86 | MP0005025_abnormal_response_to | 1.09916562 |
| 87 | MP0003690_abnormal_glial_cell | 1.09384933 |
| 88 | MP0005023_abnormal_wound_healing | 1.09080618 |
| 89 | MP0004233_abnormal_muscle_weight | 1.08096736 |
| 90 | MP0004947_skin_inflammation | 1.07179044 |
| 91 | MP0001730_embryonic_growth_arrest | 1.04882966 |
| 92 | MP0000604_amyloidosis | 1.04708466 |
| 93 | MP0005375_adipose_tissue_phenotype | 1.02973183 |
| 94 | MP0002429_abnormal_blood_cell | 1.02482876 |
| 95 | MP0003077_abnormal_cell_cycle | 1.00227154 |
| 96 | MP0002419_abnormal_innate_immunity | 0.98871177 |
| 97 | MP0003693_abnormal_embryo_hatching | 0.98382429 |
| 98 | MP0003984_embryonic_growth_retardation | 0.98309453 |
| 99 | MP0001672_abnormal_embryogenesis/_devel | 0.96661790 |
| 100 | MP0005380_embryogenesis_phenotype | 0.96661790 |
| 101 | MP0003045_fibrosis | 0.96173235 |
| 102 | MP0005397_hematopoietic_system_phenotyp | 0.95676288 |
| 103 | MP0001545_abnormal_hematopoietic_system | 0.95676288 |
| 104 | MP0002088_abnormal_embryonic_growth/wei | 0.95374482 |
| 105 | MP0001851_eye_inflammation | 0.93609749 |
| 106 | MP0001853_heart_inflammation | 0.92593286 |
| 107 | MP0002086_abnormal_extraembryonic_tissu | 0.91374770 |
| 108 | MP0005385_cardiovascular_system_phenoty | 0.91182158 |
| 109 | MP0001544_abnormal_cardiovascular_syste | 0.91182158 |
| 110 | MP0004883_abnormal_blood_vessel | 0.90791322 |
| 111 | MP0005266_abnormal_metabolism | 0.89347916 |
| 112 | MP0005075_abnormal_melanosome_morpholog | 0.86184963 |
| 113 | MP0002166_altered_tumor_susceptibility | 0.86159311 |
| 114 | MP0001663_abnormal_digestive_system | 0.85778207 |
| 115 | MP0005620_abnormal_muscle_contractility | 0.85726024 |
| 116 | MP0000609_abnormal_liver_physiology | 0.85377707 |
| 117 | MP0003300_gastrointestinal_ulcer | 0.84550913 |
| 118 | MP0005671_abnormal_response_to | 0.84284874 |
| 119 | MP0008004_abnormal_stomach_pH | 0.83650311 |
| 120 | MP0002277_abnormal_respiratory_mucosa | 0.83478331 |
| 121 | MP0003448_altered_tumor_morphology | 0.83453924 |
| 122 | MP0002019_abnormal_tumor_incidence | 0.83295019 |
| 123 | MP0002933_joint_inflammation | 0.82376107 |
| 124 | MP0008260_abnormal_autophagy | 0.81968552 |
| 125 | MP0003567_abnormal_fetal_cardiomyocyte | 0.81795170 |
| 126 | MP0008874_decreased_physiological_sensi | 0.81359065 |
| 127 | MP0003137_abnormal_impulse_conducting | 0.80862602 |
| 128 | MP0000490_abnormal_crypts_of | 0.79782887 |
| 129 | MP0001845_abnormal_inflammatory_respons | 0.78570149 |
| 130 | MP0008775_abnormal_heart_ventricle | 0.78052493 |
| 131 | MP0001697_abnormal_embryo_size | 0.78018576 |
| 132 | MP0003091_abnormal_cell_migration | 0.73288900 |
| 133 | MP0003656_abnormal_erythrocyte_physiolo | 0.71533566 |
| 134 | MP0000249_abnormal_blood_vessel | 0.69229711 |
| 135 | MP0009763_increased_sensitivity_to | 0.69212899 |
| 136 | MP0005390_skeleton_phenotype | 0.67465460 |
| 137 | MP0005164_abnormal_response_to | 0.64257127 |
| 138 | MP0005167_abnormal_blood-brain_barrier | 0.63696515 |
| 139 | MP0001986_abnormal_taste_sensitivity | 0.63620677 |
| 140 | MP0004808_abnormal_hematopoietic_stem | 0.63402643 |
| 141 | MP0003795_abnormal_bone_structure | 0.61347347 |
| 142 | MP0002006_tumorigenesis | 0.60323241 |
| 143 | MP0002254_reproductive_system_inflammat | 0.59369107 |
| 144 | MP0000920_abnormal_myelination | 0.58674596 |
| 145 | MP0002693_abnormal_pancreas_physiology | 0.56129299 |
| 146 | MP0000015_abnormal_ear_pigmentation | 0.49682822 |
| 147 | MP0005319_abnormal_enzyme/_coenzyme | 0.49053441 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber splitting (HP:0003555) | 4.79792543 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 4.75358198 |
| 3 | Exercise-induced myalgia (HP:0003738) | 4.65191527 |
| 4 | Myositis (HP:0100614) | 4.54411355 |
| 5 | Mediastinal lymphadenopathy (HP:0100721) | 4.51962362 |
| 6 | Meningitis (HP:0001287) | 4.44169042 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.39721810 |
| 8 | Orchitis (HP:0100796) | 4.33153196 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 4.12786503 |
| 10 | Optic neuritis (HP:0100653) | 4.12786503 |
| 11 | Difficulty running (HP:0009046) | 4.10356740 |
| 12 | Obstructive lung disease (HP:0006536) | 3.91171076 |
| 13 | Chronic obstructive pulmonary disease (HP:0006510) | 3.91171076 |
| 14 | Vasculitis (HP:0002633) | 3.89615472 |
| 15 | Stomatitis (HP:0010280) | 3.76130315 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.73480249 |
| 17 | Hyporeflexia of lower limbs (HP:0002600) | 3.64259373 |
| 18 | Muscle fiber inclusion bodies (HP:0100299) | 3.62531763 |
| 19 | Recurrent skin infections (HP:0001581) | 3.62144973 |
| 20 | Increased connective tissue (HP:0009025) | 3.60731243 |
| 21 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.52124526 |
| 22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.49742640 |
| 23 | Gastrointestinal infarctions (HP:0005244) | 3.45543830 |
| 24 | Increased IgE level (HP:0003212) | 3.45525382 |
| 25 | Recurrent sinusitis (HP:0011108) | 3.43867198 |
| 26 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.40280775 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 3.40280775 |
| 28 | Ventricular tachycardia (HP:0004756) | 3.37065618 |
| 29 | Asymmetric septal hypertrophy (HP:0001670) | 3.36380892 |
| 30 | Myopathic facies (HP:0002058) | 3.26686793 |
| 31 | Encephalitis (HP:0002383) | 3.26607328 |
| 32 | Myoglobinuria (HP:0002913) | 3.22571232 |
| 33 | Spontaneous hematomas (HP:0007420) | 3.20567429 |
| 34 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.19780510 |
| 35 | Urticaria (HP:0001025) | 3.18507936 |
| 36 | Lymphopenia (HP:0001888) | 3.18245106 |
| 37 | Pustule (HP:0200039) | 3.15978349 |
| 38 | Nemaline bodies (HP:0003798) | 3.15971149 |
| 39 | Ulnar bowing (HP:0003031) | 3.10498419 |
| 40 | Difficulty climbing stairs (HP:0003551) | 3.09814137 |
| 41 | Colitis (HP:0002583) | 3.09176170 |
| 42 | Pulmonary infiltrates (HP:0002113) | 3.06857404 |
| 43 | Calf muscle hypertrophy (HP:0008981) | 3.06186833 |
| 44 | Gingivitis (HP:0000230) | 3.04219039 |
| 45 | EMG: myopathic abnormalities (HP:0003458) | 3.03067761 |
| 46 | Chest pain (HP:0100749) | 3.02089276 |
| 47 | Round ear (HP:0100830) | 3.01256972 |
| 48 | Multiple enchondromatosis (HP:0005701) | 3.00862460 |
| 49 | Panhypogammaglobulinemia (HP:0003139) | 3.00787101 |
| 50 | Rhabdomyolysis (HP:0003201) | 3.00608816 |
| 51 | Sudden death (HP:0001699) | 2.92344734 |
| 52 | Ulnar deviation of the wrist (HP:0003049) | 2.92230384 |
| 53 | Osteomyelitis (HP:0002754) | 2.90607721 |
| 54 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.89792481 |
| 55 | Keratoconjunctivitis sicca (HP:0001097) | 2.89028922 |
| 56 | Cellulitis (HP:0100658) | 2.86757353 |
| 57 | Hemoptysis (HP:0002105) | 2.74030660 |
| 58 | Keratoconjunctivitis (HP:0001096) | 2.66703423 |
| 59 | Recurrent pneumonia (HP:0006532) | 2.59557746 |
| 60 | Progressive muscle weakness (HP:0003323) | 2.57328141 |
| 61 | Gastrointestinal stroma tumor (HP:0100723) | 2.54883124 |
| 62 | Recurrent abscess formation (HP:0002722) | 2.54417304 |
| 63 | Muscle stiffness (HP:0003552) | 2.53908932 |
| 64 | Inflammation of the large intestine (HP:0002037) | 2.51388488 |
| 65 | Type 1 muscle fiber predominance (HP:0003803) | 2.50788134 |
| 66 | Prolonged bleeding time (HP:0003010) | 2.49099591 |
| 67 | Testicular atrophy (HP:0000029) | 2.49096957 |
| 68 | Polycythemia (HP:0001901) | 2.43463028 |
| 69 | Sepsis (HP:0100806) | 2.43378818 |
| 70 | Gastrointestinal inflammation (HP:0004386) | 2.43012373 |
| 71 | Hypochromic anemia (HP:0001931) | 2.40806997 |
| 72 | Agammaglobulinemia (HP:0004432) | 2.40249260 |
| 73 | Recurrent lower respiratory tract infections (HP:0002783) | 2.38606199 |
| 74 | Loss of speech (HP:0002371) | 2.38498836 |
| 75 | Petechiae (HP:0000967) | 2.36399505 |
| 76 | Increased IgM level (HP:0003496) | 2.34719609 |
| 77 | Pulmonary embolism (HP:0002204) | 2.34593407 |
| 78 | EMG: neuropathic changes (HP:0003445) | 2.31970884 |
| 79 | Areflexia of lower limbs (HP:0002522) | 2.31795074 |
| 80 | Arterial thrombosis (HP:0004420) | 2.30719829 |
| 81 | Purpura (HP:0000979) | 2.30277666 |
| 82 | Abnormality of T cells (HP:0002843) | 2.30114992 |
| 83 | Abnormality of T cell physiology (HP:0011840) | 2.29390463 |
| 84 | Neck muscle weakness (HP:0000467) | 2.27376533 |
| 85 | Systemic lupus erythematosus (HP:0002725) | 2.25997635 |
| 86 | Epistaxis (HP:0000421) | 2.24022277 |
| 87 | Axonal loss (HP:0003447) | 2.23698251 |
| 88 | Chronic otitis media (HP:0000389) | 2.22475346 |
| 89 | Episodic fever (HP:0001954) | 2.22468402 |
| 90 | Papilloma (HP:0012740) | 2.22393436 |
| 91 | Verrucae (HP:0200043) | 2.22393436 |
| 92 | Recurrent fungal infections (HP:0002841) | 2.22301104 |
| 93 | Abnormality of the pleura (HP:0002103) | 2.21541020 |
| 94 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.19522486 |
| 95 | Abnormality of glycolipid metabolism (HP:0010969) | 2.19522486 |
| 96 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.19522486 |
| 97 | Distal arthrogryposis (HP:0005684) | 2.19506103 |
| 98 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.17505776 |
| 99 | IgM deficiency (HP:0002850) | 2.16037326 |
| 100 | T lymphocytopenia (HP:0005403) | 2.15500582 |
| 101 | Achilles tendon contracture (HP:0001771) | 2.15136195 |
| 102 | Abnormality of macrophages (HP:0004311) | 2.14792871 |
| 103 | Subaortic stenosis (HP:0001682) | 2.13897554 |
| 104 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.13897554 |
| 105 | Leukocytosis (HP:0001974) | 2.13063924 |
| 106 | Granulocytopenia (HP:0001913) | 2.12191400 |
| 107 | Distal lower limb muscle weakness (HP:0009053) | 2.10466229 |
| 108 | Hypochromic microcytic anemia (HP:0004840) | 2.10043953 |
| 109 | Hypoplastic ischia (HP:0003175) | 2.09481622 |
| 110 | Abnormality of T cell number (HP:0011839) | 2.09336898 |
| 111 | Hypergammaglobulinemia (HP:0010702) | 2.09209862 |
| 112 | Gingival bleeding (HP:0000225) | 2.08457260 |
| 113 | Abnormality of the peritoneum (HP:0002585) | 2.06776394 |
| 114 | Anorexia (HP:0002039) | 2.06671030 |
| 115 | Premature loss of primary teeth (HP:0006323) | 2.06178629 |
| 116 | Recurrent viral infections (HP:0004429) | 2.04937512 |
| 117 | Cerebral aneurysm (HP:0004944) | 2.04574922 |
| 118 | Abnormality of the endocardium (HP:0004306) | 2.04525609 |
| 119 | Eczematoid dermatitis (HP:0000976) | 2.04417288 |
| 120 | Paralysis (HP:0003470) | 2.04138256 |
| 121 | Arthralgia (HP:0002829) | 2.03362541 |
| 122 | Emphysema (HP:0002097) | 2.02881467 |
| 123 | Skin ulcer (HP:0200042) | 2.02732184 |
| 124 | Cheilitis (HP:0100825) | 2.02513523 |
| 125 | Recurrent bacterial skin infections (HP:0005406) | 2.01916562 |
| 126 | Viral hepatitis (HP:0006562) | 2.01166139 |
| 127 | Amyloidosis (HP:0011034) | 2.00949983 |
| 128 | Metaphyseal cupping (HP:0003021) | 2.00783511 |
| 129 | Restrictive lung disease (HP:0002091) | 2.00154610 |
| 130 | Abnormality of the Achilles tendon (HP:0005109) | 1.99268666 |
| 131 | Hyperglycinuria (HP:0003108) | 1.99248617 |
| 132 | Increased cerebral lipofuscin (HP:0011813) | 1.98253792 |
| 133 | Myocardial infarction (HP:0001658) | 1.97611255 |
| 134 | Skin rash (HP:0000988) | 1.97111177 |
| 135 | Abnormality of the calf musculature (HP:0001430) | 1.96886399 |
| 136 | Small epiphyses (HP:0010585) | 1.94907608 |
| 137 | Gangrene (HP:0100758) | 1.94711769 |
| 138 | Polyneuropathy (HP:0001271) | 1.94362490 |
| 139 | Cerebral hypomyelination (HP:0006808) | 1.93331846 |
| 140 | Abnormality of the salivary glands (HP:0010286) | 1.93251311 |
| 141 | IgA deficiency (HP:0002720) | 1.92754745 |
| 142 | Hepatosplenomegaly (HP:0001433) | 1.92010498 |
| 143 | Recurrent bronchitis (HP:0002837) | 1.91299106 |
| 144 | Vacuolated lymphocytes (HP:0001922) | 1.90225373 |
| 145 | Autoimmune thrombocytopenia (HP:0001973) | 1.90102990 |
| 146 | Lipoatrophy (HP:0100578) | 1.89618630 |
| 147 | Intestinal fistula (HP:0100819) | 1.89081058 |
| 148 | Rib fusion (HP:0000902) | 1.87522739 |
| 149 | Calcaneovalgus deformity (HP:0001848) | 1.86123868 |
| 150 | Diaphragmatic weakness (HP:0009113) | 1.85549924 |
| 151 | Rectovaginal fistula (HP:0000143) | 1.82241728 |
| 152 | Rectal fistula (HP:0100590) | 1.82241728 |
| 153 | Ependymoma (HP:0002888) | 1.79374333 |
| 154 | Frequent falls (HP:0002359) | 1.78910815 |
| 155 | Large for gestational age (HP:0001520) | 1.78518031 |
| 156 | Increased serum ferritin (HP:0003281) | 1.78510215 |
| 157 | Muscle fibrillation (HP:0010546) | 1.78158640 |
| 158 | Abnormality of glycine metabolism (HP:0010895) | 1.75703281 |
| 159 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.75703281 |
| 160 | Abnormality of the nasal mucosa (HP:0000433) | 1.75512918 |
| 161 | Dysostosis multiplex (HP:0000943) | 1.74810517 |
| 162 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.74343575 |
| 163 | Right ventricular cardiomyopathy (HP:0011663) | 1.74105187 |
| 164 | Vertebral clefting (HP:0008428) | 1.73689490 |
| 165 | Myotonia (HP:0002486) | 1.71694091 |
| 166 | Dilated cardiomyopathy (HP:0001644) | 1.71328350 |
| 167 | Vaginal fistula (HP:0004320) | 1.71232933 |
| 168 | Nasal polyposis (HP:0100582) | 1.70919512 |
| 169 | Abnormality of the umbilical cord (HP:0010881) | 1.70878327 |
| 170 | Generalized amyotrophy (HP:0003700) | 1.68257920 |
| 171 | Bundle branch block (HP:0011710) | 1.67353664 |
| 172 | Abnormality of the ischium (HP:0003174) | 1.67089864 |
| 173 | Ileus (HP:0002595) | 1.67044125 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.91394034 |
| 2 | MAP4K1 | 3.74748840 |
| 3 | TTN | 3.14336372 |
| 4 | TRIB3 | 3.11599936 |
| 5 | IRAK4 | 3.00121937 |
| 6 | PRPF4B | 2.97887453 |
| 7 | MAP3K10 | 2.97315569 |
| 8 | ERN1 | 2.90217897 |
| 9 | ICK | 2.54496746 |
| 10 | CDK12 | 2.47071874 |
| 11 | EPHA2 | 2.21710122 |
| 12 | GRK6 | 2.18963440 |
| 13 | TNK2 | 2.16451965 |
| 14 | EPHB1 | 2.14127597 |
| 15 | STK10 | 2.11967970 |
| 16 | MAP3K14 | 2.11301169 |
| 17 | CSF1R | 1.92685693 |
| 18 | MAP3K13 | 1.91130416 |
| 19 | CSK | 1.89203491 |
| 20 | FES | 1.75600108 |
| 21 | OBSCN | 1.73339452 |
| 22 | SIK3 | 1.68262549 |
| 23 | PKN2 | 1.64125433 |
| 24 | IKBKE | 1.60806288 |
| 25 | MAP2K3 | 1.55157863 |
| 26 | MAP3K11 | 1.54833353 |
| 27 | PHKG1 | 1.54090660 |
| 28 | PHKG2 | 1.54090660 |
| 29 | BLK | 1.52247266 |
| 30 | SIK2 | 1.51196938 |
| 31 | TYK2 | 1.49314478 |
| 32 | MATK | 1.35921042 |
| 33 | TGFBR2 | 1.33385152 |
| 34 | FGR | 1.29177270 |
| 35 | BUB1 | 1.27572033 |
| 36 | SMG1 | 1.26365464 |
| 37 | LRRK2 | 1.25345045 |
| 38 | BCKDK | 1.21720625 |
| 39 | TAOK2 | 1.16555265 |
| 40 | MAP3K1 | 1.16380501 |
| 41 | NEK2 | 1.13948068 |
| 42 | TBK1 | 1.10188036 |
| 43 | FGFR4 | 1.07635314 |
| 44 | BMX | 1.07549454 |
| 45 | MAPK15 | 1.06766089 |
| 46 | JAK2 | 1.06738874 |
| 47 | RPS6KB2 | 1.05783761 |
| 48 | PAK4 | 1.05350986 |
| 49 | MARK2 | 1.03281247 |
| 50 | TYRO3 | 1.03122050 |
| 51 | TXK | 1.03105741 |
| 52 | EEF2K | 0.99148861 |
| 53 | NEK1 | 0.98556792 |
| 54 | BMPR2 | 0.98103688 |
| 55 | PIM1 | 0.96786419 |
| 56 | DDR2 | 0.96481620 |
| 57 | PINK1 | 0.94031530 |
| 58 | STK4 | 0.93659221 |
| 59 | KSR2 | 0.93621093 |
| 60 | CDK19 | 0.90933774 |
| 61 | DMPK | 0.90469885 |
| 62 | ALK | 0.90148190 |
| 63 | MAP3K3 | 0.89232922 |
| 64 | TESK2 | 0.86769311 |
| 65 | CDK4 | 0.84789787 |
| 66 | PRKD1 | 0.84226268 |
| 67 | MAPK12 | 0.83712886 |
| 68 | ITK | 0.83668401 |
| 69 | IRAK3 | 0.82493351 |
| 70 | MAPK11 | 0.82281613 |
| 71 | MAPK7 | 0.80722303 |
| 72 | MAP2K2 | 0.80254442 |
| 73 | MAP3K8 | 0.79597070 |
| 74 | TRPM7 | 0.79539288 |
| 75 | IRAK2 | 0.79340102 |
| 76 | KDR | 0.78712890 |
| 77 | PDK2 | 0.77941886 |
| 78 | MTOR | 0.77814628 |
| 79 | IKBKB | 0.77519803 |
| 80 | MARK3 | 0.77410035 |
| 81 | KIT | 0.74892561 |
| 82 | PRKD2 | 0.74814453 |
| 83 | IRAK1 | 0.74518205 |
| 84 | NEK9 | 0.73389490 |
| 85 | CDK7 | 0.73373672 |
| 86 | HCK | 0.72886843 |
| 87 | TAOK3 | 0.71757462 |
| 88 | PRKCQ | 0.71580548 |
| 89 | ZAP70 | 0.71373668 |
| 90 | PRKG2 | 0.70734005 |
| 91 | TTK | 0.67771942 |
| 92 | GSK3A | 0.67116022 |
| 93 | BTK | 0.64975298 |
| 94 | NME2 | 0.64914410 |
| 95 | SIK1 | 0.64719909 |
| 96 | TEC | 0.64077800 |
| 97 | MAPKAPK3 | 0.62382674 |
| 98 | DYRK3 | 0.61597205 |
| 99 | PIK3CG | 0.61429132 |
| 100 | WEE1 | 0.61372697 |
| 101 | JAK1 | 0.59618978 |
| 102 | MAP3K7 | 0.58822641 |
| 103 | PRKAA1 | 0.58336368 |
| 104 | GRK1 | 0.56576446 |
| 105 | PTK6 | 0.56467099 |
| 106 | HIPK2 | 0.56406787 |
| 107 | DYRK1B | 0.56011212 |
| 108 | YES1 | 0.55984715 |
| 109 | RPS6KC1 | 0.55035798 |
| 110 | RPS6KL1 | 0.55035798 |
| 111 | TAOK1 | 0.54962398 |
| 112 | CLK1 | 0.53914961 |
| 113 | RPS6KA6 | 0.53140509 |
| 114 | FYN | 0.52092780 |
| 115 | SYK | 0.52084702 |
| 116 | LCK | 0.51667235 |
| 117 | PDK3 | 0.51329388 |
| 118 | PDK4 | 0.51329388 |
| 119 | PRKAA2 | 0.51236586 |
| 120 | MAP2K6 | 0.51151219 |
| 121 | FGFR3 | 0.48680866 |
| 122 | PKN1 | 0.47635138 |
| 123 | CHUK | 0.47617183 |
| 124 | RIPK1 | 0.47406784 |
| 125 | CAMKK1 | 0.47093850 |
| 126 | ILK | 0.46411662 |
| 127 | MAP3K5 | 0.46399563 |
| 128 | LYN | 0.45883513 |
| 129 | CDC42BPA | 0.44931827 |
| 130 | MAPKAPK2 | 0.44165493 |
| 131 | MAP3K6 | 0.44057588 |
| 132 | JAK3 | 0.43212864 |
| 133 | STK11 | 0.43046039 |
| 134 | SGK3 | 0.43044310 |
| 135 | PRKCH | 0.42487923 |
| 136 | PDK1 | 0.42032052 |
| 137 | MAPK4 | 0.39693707 |
| 138 | EGFR | 0.39234069 |
| 139 | PDPK1 | 0.38693447 |
| 140 | PTK2B | 0.36929372 |
| 141 | DAPK2 | 0.34770655 |
| 142 | RPS6KA2 | 0.33762277 |
| 143 | GRK7 | 0.31943042 |
| 144 | ARAF | 0.30931536 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.36480941 |
| 2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.12125096 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.10647338 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.83938428 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.73729451 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.56000470 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.50141226 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.41716292 |
| 9 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.31474769 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.30193966 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.96984823 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.96077349 |
| 13 | Base excision repair_Homo sapiens_hsa03410 | 1.89378496 |
| 14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.86239501 |
| 15 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.75199102 |
| 16 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.74133352 |
| 17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.73185859 |
| 18 | Mismatch repair_Homo sapiens_hsa03430 | 1.72794929 |
| 19 | Sulfur relay system_Homo sapiens_hsa04122 | 1.66663933 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.59167865 |
| 21 | Carbon metabolism_Homo sapiens_hsa01200 | 1.55866303 |
| 22 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.54796499 |
| 23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.48253845 |
| 24 | DNA replication_Homo sapiens_hsa03030 | 1.44719653 |
| 25 | Lysosome_Homo sapiens_hsa04142 | 1.39401945 |
| 26 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.37099739 |
| 27 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.36856596 |
| 28 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.35562930 |
| 29 | Malaria_Homo sapiens_hsa05144 | 1.34953528 |
| 30 | Phagosome_Homo sapiens_hsa04145 | 1.34804864 |
| 31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.34090724 |
| 32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.33415724 |
| 33 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.31867792 |
| 34 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.30770392 |
| 35 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.30682077 |
| 36 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.30008427 |
| 37 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.24123373 |
| 38 | Other glycan degradation_Homo sapiens_hsa00511 | 1.22574608 |
| 39 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.21258004 |
| 40 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.20603488 |
| 41 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.20144498 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.19933341 |
| 43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.16778689 |
| 44 | Galactose metabolism_Homo sapiens_hsa00052 | 1.16568778 |
| 45 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.14357937 |
| 46 | Leishmaniasis_Homo sapiens_hsa05140 | 1.12795744 |
| 47 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.12782450 |
| 48 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.11405510 |
| 49 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.10359387 |
| 50 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.06917900 |
| 51 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.06884982 |
| 52 | Insulin resistance_Homo sapiens_hsa04931 | 1.06131831 |
| 53 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.05957462 |
| 54 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.05955774 |
| 55 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.04422041 |
| 56 | Shigellosis_Homo sapiens_hsa05131 | 1.03824249 |
| 57 | Hepatitis B_Homo sapiens_hsa05161 | 1.03594206 |
| 58 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.03229481 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 1.02426353 |
| 60 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.01313185 |
| 61 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.00565502 |
| 62 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.95538001 |
| 63 | Pertussis_Homo sapiens_hsa05133 | 0.94584137 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.93653607 |
| 65 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.93027307 |
| 66 | Apoptosis_Homo sapiens_hsa04210 | 0.90197972 |
| 67 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.89496282 |
| 68 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.88743789 |
| 69 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.88283788 |
| 70 | RNA transport_Homo sapiens_hsa03013 | 0.87690129 |
| 71 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.87609779 |
| 72 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.86344887 |
| 73 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.86303198 |
| 74 | Lysine degradation_Homo sapiens_hsa00310 | 0.83258502 |
| 75 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83019495 |
| 76 | Platelet activation_Homo sapiens_hsa04611 | 0.83018819 |
| 77 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81638231 |
| 78 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.81207445 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81179554 |
| 80 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.80002747 |
| 81 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.79690679 |
| 82 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.78833704 |
| 83 | Salmonella infection_Homo sapiens_hsa05132 | 0.74533786 |
| 84 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.74077884 |
| 85 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.73469191 |
| 86 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.73074395 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.72971739 |
| 88 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.72715441 |
| 89 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.72442096 |
| 90 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.70246668 |
| 91 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.70215866 |
| 92 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.70007060 |
| 93 | Legionellosis_Homo sapiens_hsa05134 | 0.69821634 |
| 94 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.69758512 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.69197915 |
| 96 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.68583564 |
| 97 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.68144197 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66933025 |
| 99 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.66621555 |
| 100 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.65170360 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.63397330 |
| 102 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.63394397 |
| 103 | Tuberculosis_Homo sapiens_hsa05152 | 0.63370846 |
| 104 | Tight junction_Homo sapiens_hsa04530 | 0.63122753 |
| 105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.63092101 |
| 106 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.62415033 |
| 107 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.62385828 |
| 108 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.61979259 |
| 109 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.61481117 |
| 110 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60981496 |
| 111 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60756273 |
| 112 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.60730419 |
| 113 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.60415775 |
| 114 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.58879992 |
| 115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58426214 |
| 116 | Measles_Homo sapiens_hsa05162 | 0.57667199 |
| 117 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.56154634 |
| 118 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56037935 |
| 119 | Focal adhesion_Homo sapiens_hsa04510 | 0.55467061 |
| 120 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54893070 |
| 121 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54813780 |
| 122 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.53051854 |
| 123 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52344466 |
| 124 | Adherens junction_Homo sapiens_hsa04520 | 0.52183442 |
| 125 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.52073691 |
| 126 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51375228 |
| 127 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.50811031 |
| 128 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.49734146 |
| 129 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.49726577 |
| 130 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.49435456 |
| 131 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.49425012 |
| 132 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.49403644 |
| 133 | Spliceosome_Homo sapiens_hsa03040 | 0.47689946 |
| 134 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.46780930 |
| 135 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.46760680 |
| 136 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46115290 |
| 137 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.43799504 |
| 138 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.43490363 |
| 139 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.43446984 |
| 140 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.42595091 |
| 141 | Ribosome_Homo sapiens_hsa03010 | 0.42238939 |
| 142 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.39926937 |
| 143 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.39619757 |
| 144 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39187173 |
| 145 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37458717 |
| 146 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.36637067 |
| 147 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.35879572 |
| 148 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.34469304 |
| 149 | Amoebiasis_Homo sapiens_hsa05146 | 0.34229175 |
| 150 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.32292705 |
| 151 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.28503329 |
| 152 | Colorectal cancer_Homo sapiens_hsa05210 | 0.25317743 |
| 153 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.25057640 |
| 154 | Bladder cancer_Homo sapiens_hsa05219 | 0.23547323 |
| 155 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.22877315 |
| 156 | Long-term potentiation_Homo sapiens_hsa04720 | 0.22638171 |
| 157 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.20989274 |

